In 2021, 1 567 cases of mumps were reported to ECDC by 27 European Union/European Economic Area(EU/EEA) Member States, with an overall notification rate of 0.4 cases per 100 000 population. This wassignificantly lower than the notification rates reported during the previous four years (range 1.7-4.2).
Outsourced microbiological support to hospital-based surveillance of CDI aims to increase the capacity of laboratories in EU/EEA Member States to perform diagnostic practices with high diagnostic accuracy and acquire comparable typing data from C. difficile isolates.
This document provides an update on the safety of substances of human origin (SoHO) in relation to COVID-19. It reassesses the risk and proposes revised mitigation measures for preventing transmission through SoHO.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 5-11 June 2023 and includes updates on Middle East respiratory syndrome coronavirus (MERS-CoV), COVID-19, Mpox, Marburg virus disease and West Nile virus.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 28 May - 3 June 2023 and includes updates on COVID-19, West Nile virus, Legionnaires' disease, avian influenza, Marburg virus disease, cholera, and fungal meningitis.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 21-27 May 2023 and includes updates on COVID-19, influenza, Marburg virus disease, poliomyelitis, extensively drug-resistant Pseudomonas aeruginosa, and suspected fungal meningitis.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 14-17 May 2023 and includes updates on Legionnaires’ disease, avian or animal influenza (H5), MDR S.Typhi, Marburg virus disease and antifungal-resistant Trichophyton indotineae.